Medically Reviewed by Dr. Brijen L. Joshi, MD | Vita Nova Ketamine & Wellness Clinic
For Baltimore professionals experiencing NAD+ brain fog and NAD+ chronic fatigue Baltimore patients are asking about in growing numbers — the answer may lie in one of the most fundamental molecules in human biology. Nicotinamide adenine dinucleotide (NAD+) is the coenzyme your mitochondria require to produce cellular energy, and when its levels decline — through aging, chronic stress, illness, or the lingering effects of COVID-19 — the result is exactly what so many high-functioning professionals describe: a persistent cognitive fog, an exhaustion that sleep does not fix, and a performance gap that no amount of caffeine closes. IV NAD+ therapy delivers this critical molecule directly into the bloodstream at therapeutic concentrations, bypassing the absorption limitations of oral supplements entirely.
What Is NAD+ and Why Does It Matter for Brain and Energy Function?
NAD+ — nicotinamide adenine dinucleotide — is a coenzyme found in every living cell in the human body. It is not a vitamin or a supplement in the conventional sense. It is a fundamental molecular tool without which your cells cannot generate usable energy. The science is unambiguous: without NAD+, the mitochondria — your cells’ energy-producing structures — cannot complete the biochemical processes that convert food into adenosine triphosphate (ATP), the actual energy currency your brain and body run on.
Beyond energy production, NAD+ plays critical roles in DNA repair, regulation of circadian rhythms, activation of sirtuins (longevity-associated proteins), and neurological function. According to research published in the journal Cell Metabolism, NAD+ levels decline significantly with age — by as much as 50 percent between the ages of 40 and 60. This decline is not gradual and inconsequential; it is biologically meaningful and clinically observable in the form of fatigue, cognitive slowing, reduced stress resilience, and impaired recovery.
For a comprehensive overview of how NAD+ IV therapy works across wellness applications, read our Ultimate Guide to NAD+ IV Therapy for Baltimore Residents.
The Mitochondria-Energy-Cognition Connection: Why Your Brain Fog Has a Biological Root
The brain is the most metabolically demanding organ in the human body. Although it accounts for only about 2 percent of body weight, it consumes approximately 20 percent of the body’s total energy. That energy is produced almost entirely by mitochondria — and mitochondria cannot function without NAD+.
When NAD+ levels are adequate, mitochondria operate at peak efficiency: neurons fire rapidly and clearly, neurotransmitter synthesis is supported, and the prefrontal cortex — the region responsible for executive function, decision-making, and working memory — performs at its cognitive best. When NAD+ is depleted, mitochondrial function degrades. The neurons that power clear thinking become energy-starved. The result is what patients describe as brain fog: a pervasive cloudiness, reduced processing speed, difficulty concentrating, word retrieval problems, and a general sense that cognitive performance has been turned down by several notches.
The ATP Production Chain — Simplified
Here is the simplified version of the biochemistry that matters clinically: food is broken down into acetyl-CoA, which enters the mitochondria’s Krebs cycle. The Krebs cycle produces NADH (NAD+ carrying electrons). These electrons travel through the electron transport chain — a series of protein complexes in the inner mitochondrial membrane — generating ATP in the process. NAD+ is regenerated in the process and cycles back to accept more electrons. Without adequate NAD+ to carry electrons through this chain, ATP production slows, cellular energy is throttled, and the brain — first among organs to feel the shortage — signals this as fatigue and fog.
Why Chronic Fatigue Is Not Simply Tiredness
Chronic fatigue is not the tiredness that follows a poor night of sleep. It is a persistent, medically significant reduction in energy that does not resolve with rest, is disproportionate to activity level, and typically coexists with cognitive symptoms including brain fog, impaired short-term memory, and reduced mental stamina. The CDC recognizes Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) as a serious multi-system illness affecting an estimated 3.3 million Americans. Post-COVID fatigue and brain fog have dramatically expanded the population experiencing these symptoms.
🔬 The NAD+ — Brain Fog Connection in Plain Language
Low NAD+ → mitochondria produce less ATP → neurons become energy-starved → brain function slows → brain fog, fatigue, reduced cognitive performance. IV NAD+ therapy replenishes the coenzyme at the source, restoring the mitochondrial energy chain from the inside out. This is not symptom management — it is biochemical restoration.
Post-COVID Brain Fog and Fatigue: Why NAD+ Is Emerging as a Key Therapeutic Target
Post-acute sequelae of SARS-CoV-2 infection — commonly called Long COVID — has introduced a massive new population of patients experiencing persistent brain fog and fatigue. The NIH RECOVER initiative estimates that between 10 and 30 percent of COVID-19 survivors experience symptoms lasting beyond 12 weeks, with brain fog and fatigue among the most commonly reported.
Emerging research points to mitochondrial dysfunction and NAD+ depletion as central mechanisms in Long COVID symptoms. SARS-CoV-2 infection appears to trigger excessive activation of PARP enzymes — proteins that consume NAD+ rapidly during DNA damage repair — creating a significant NAD+ deficit in the aftermath of infection. A 2022 paper in Nature Aging by Xie et al. proposed NAD+ precursor supplementation as a rational intervention for Long COVID on precisely these mechanistic grounds.
For Baltimore professionals who contracted COVID and have not returned to their pre-infection cognitive baseline — months or even years later — IV NAD+ therapy at Vita Nova represents a clinically grounded, mechanistically sound option that addresses the underlying biology rather than managing symptoms.
Why Baltimore Professionals Are Turning to NAD+ IV Therapy
Baltimore is home to a high concentration of cognitively demanding professionals — attorneys at the city’s major law firms, physicians and surgeons at Johns Hopkins and the University of Maryland Medical System, technology and biotech workers, financial professionals, and executives across the region’s thriving business corridor. For these individuals, cognitive performance is not a lifestyle preference — it is professional currency.
The profile of a Vita Nova NAD+ patient is often a 35 to 55 year old professional who is objectively functioning — meeting deadlines, maintaining responsibilities — but operating at 70 to 80 percent of their former cognitive capacity. They describe a sustained mental effort that previously came easily now requiring active concentration. They report a fatigue that does not respond to sleep, exercise, or dietary changes. They have typically ruled out thyroid dysfunction, anemia, and sleep disorders. What remains is a mitochondrial energy deficit that is biochemically measurable and therapeutically addressable.
For professionals who cannot afford cognitive decline — whether measured in billable hours, patient outcomes, or strategic decisions — IV NAD+ therapy at Vita Nova offers a physician-supervised, evidence-informed intervention that targets the root biology. Visit our Baltimore wellness center overview to understand the full scope of what Vita Nova offers high-performing patients.
IV NAD+ vs. Oral Supplements: Why the Delivery Route Changes Everything
Oral NAD+ precursors — primarily nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — are widely available and broadly marketed. They are also biochemically limited in ways that matter clinically for patients with significant fatigue or brain fog.
When taken orally, NAD+ precursors must survive the gastrointestinal tract, be absorbed through the intestinal wall, be converted through multiple enzymatic steps into NAD+, and then reach target tissues at therapeutically relevant concentrations. Each step in this chain represents potential attrition. Absorption rates vary significantly by individual, and the concentrations achievable in plasma through oral supplementation are a fraction of what IV delivery achieves.
IV NAD+ bypasses the entire GI absorption process. The molecule is delivered directly into the bloodstream at precise, physician-calibrated doses — achieving plasma concentrations that oral supplementation cannot replicate. For patients with active symptoms — ongoing brain fog, chronic fatigue, post-COVID sequelae — the difference between oral precursors and IV NAD+ is the difference between a wellness supplement and a clinical intervention.
| Feature | IV NAD+ Therapy | Oral NR / NMN Supplements |
|---|---|---|
| Absorption | 100% bioavailability — delivered directly to bloodstream | Variable — depends on GI health, conversion enzymes, individual metabolism |
| Plasma Concentration | Therapeutic — achieves clinically meaningful NAD+ elevation | Sub-therapeutic for most active-symptom patients |
| Onset of Effect | During or within 24 to 48 hours of infusion | Weeks of consistent dosing required |
| Physician Oversight | Yes — dose calibrated to patient weight, symptoms, and response | None — standardized consumer dosing |
| Best For | Active brain fog, chronic fatigue, post-COVID, cognitive optimization | Maintenance between IV sessions, general wellness |
| Complementary Use | Often combined with B-complex, glutathione, or vitamin C in IV formula | Can supplement between IV sessions to maintain elevation |
What NAD+ IV Therapy Addresses at Vita Nova
Vita Nova’s NAD+ IV therapy in Baltimore is a physician-supervised clinical service — not a wellness spa add-on. Every protocol is evaluated and approved by Dr. Brijen L. Joshi, MD. The following are the primary presentations for which NAD+ therapy is clinically applied at Vita Nova.
Brain Fog
Brain fog is not a formal medical diagnosis but a widely recognized symptom cluster: reduced mental clarity, difficulty concentrating, slowed processing speed, impaired working memory, and word retrieval difficulties. It can result from aging-related NAD+ decline, chronic stress, post-viral illness, sleep disorders, or the cumulative effects of sustained cognitive overload. For Baltimore professionals, it manifests most visibly as the inability to perform at the level they previously took for granted — and it is frequently dismissed or misattributed by standard medical evaluations that do not assess mitochondrial function.
IV NAD+ therapy addresses brain fog at the mitochondrial level — replenishing the coenzyme that neurons require to generate the ATP that powers clear, efficient cognition. Many patients report a noticeable shift in mental clarity within 24 to 48 hours of their first infusion, with progressive improvement across a treatment series.
Chronic Fatigue
Chronic fatigue that does not respond to sleep, nutrition, or exercise is frequently rooted in cellular energy deficits — particularly mitochondrial dysfunction. When NAD+ is depleted, cells across every organ system — including muscle tissue, the immune system, and the brain — operate below their energy capacity. The subjective experience is a pervasive, unshifting exhaustion that coexists with normal lab results, frustrates standard medical investigation, and progressively impairs both professional performance and quality of life.
IV NAD+ replenishes the mitochondrial energy substrate directly, restoring the biochemical conditions for normal ATP production. Clinical experience at IV therapy centers and emerging research support meaningful fatigue reduction in patients who have failed other interventions. For a deeper look at how NAD+ affects the aging process and long-term energy, read our post on how NAD+ reverses aging — the science explained for Baltimore patients.
Post-COVID Cognitive Symptoms
For patients whose brain fog and fatigue trace directly to a COVID-19 infection — with no resolution months or years later — NAD+ IV therapy offers a mechanistically grounded intervention targeting the viral-induced mitochondrial dysfunction and NAD+ depletion that current research identifies as central to Long COVID pathophysiology. This is not a general wellness offering for this population — it is a targeted biochemical intervention for a specific, documented biological deficit.
Cognitive Optimization for High Performers
Not every NAD+ patient is symptomatic. A meaningful proportion of Vita Nova’s NAD+ patients are high-performing professionals who are not experiencing brain fog or fatigue at a clinical level but who recognize that maintaining peak NAD+ levels supports sustained cognitive performance, stress resilience, and long-term neurological health. For this group, periodic NAD+ infusions — often combined with glutathione and B-complex as part of the Vitality Circle membership — function as proactive maintenance of the biological infrastructure that professional performance depends on.
⭐ The Vitality Circle Membership
For Baltimore professionals making NAD+ IV therapy a regular part of their performance and wellness protocol, the Vitality Circle membership at $99.99 per month includes one free monthly IV benefit plus 25% off premium treatments. NAD+ therapy is available at the 25% member discount — a meaningful saving for patients who benefit from regular sessions.
Note: NAD+ is not included in the free monthly IV benefit — the free benefit applies to standard IV formulas. NAD+ members receive 25% off the standard NAD+ pricing.
The Vita Nova NAD+ Protocol: What to Expect
NAD+ IV therapy at Vita Nova is not a one-size-fits-all drip. Every protocol is physician-supervised and individually calibrated.
- Initial Consultation: Your protocol begins with a consultation with Dr. Joshi reviewing your symptoms, health history, current medications, and goals. For brain fog and fatigue presentations, Dr. Joshi assesses whether NAD+ therapy is the appropriate primary intervention or whether it should be combined with other treatments — for example, B12 supplementation for patients with confirmed deficiency, or IV hydration for patients with dehydration-related fatigue.
- Dosing: NAD+ is administered at three dose tiers at Vita Nova — 250mg, 500mg, or 750mg to 1,000mg — based on the patient’s clinical presentation, symptoms severity, and treatment goals. Higher doses are used for more significant presentations such as post-COVID fatigue or patients with significant chronic fatigue syndrome features. Dose is calibrated by Dr. Joshi, not selected by the patient.
- The Infusion Session: NAD+ is infused slowly through an IV line over 2 to 4 hours depending on dose. This is longer than standard vitamin IV drips. NAD+ must be infused slowly to minimize the transient side effects — chest tightness, nausea, or a sense of restlessness — that can occur when infused too rapidly. These effects are manageable, self-limiting, and resolve when the infusion rate is adjusted. Patients are monitored continuously throughout.
- Initial Series: For active brain fog and chronic fatigue presentations, a series of 4 to 6 infusions over 2 to 3 weeks is typically recommended to achieve sustained NAD+ elevation and meaningful symptomatic improvement. Single sessions produce results, but the cumulative effect of a full series is substantially greater.
- Maintenance: Following the initial series, monthly or bi-monthly maintenance infusions sustain elevated NAD+ levels. Many patients combine maintenance NAD+ with our complementary IV services — such as IV hydration therapy or a B12 energy shot — for a comprehensive cellular optimization protocol.
What Does NAD+ IV Therapy Actually Feel Like?
NAD+ is not like other IV infusions in terms of the in-session experience. Patients should be aware of the following:
During the infusion, particularly at higher doses, some patients experience a range of transient sensations — a feeling of pressure in the chest, mild nausea, a sense of energy or restlessness, muscle tension, or warmth. These sensations are not dangerous. They are the result of NAD+ interacting with cellular receptors and metabolic pathways throughout the body. They are dose-rate dependent — meaning they diminish when the infusion rate is slowed — and they resolve completely when the infusion ends. The clinical team at Vita Nova monitors for these responses and adjusts the infusion rate accordingly.
Most patients describe the in-session experience as intense but manageable — and the post-session experience as the reward. Many patients report a notable clarity and energy elevation in the 24 to 72 hours following a NAD+ infusion. After a full initial series, the most common patient descriptions include: sharper focus, faster cognitive processing, improved short-term memory, a sustained energy that does not crash, and a reduction in the baseline mental effort that previously characterized their workday.
What the Research Says: NAD+ and Cognitive Function
The science of NAD+ is among the most rapidly developing areas in metabolic and aging research. Several key findings are directly relevant to brain fog and chronic fatigue:
Declining NAD+ with age is well-established: Research published in Cell Metabolism (Yoshino et al., 2021) confirmed that NAD+ levels in human skeletal muscle decline significantly with age and that NMN supplementation restores them — supporting the biological rationale for NAD+ replenishment as an intervention. IV delivery achieves the NAD+ elevation that the oral route in this study approximated through high daily dosing.
NAD+ and neuroprotection: Research by Verdin (2015) in Science established NAD+’s role in sirtuin activation — proteins that regulate neuronal health, mitochondrial biogenesis, and DNA repair. Declining NAD+ reduces sirtuin activity, impairing the brain’s capacity for self-maintenance and repair, which is directly relevant to age-related cognitive decline and brain fog.
Post-COVID NAD+ depletion: Xie et al. (2022) in Nature Aging proposed that COVID-19-induced NAD+ depletion via PARP hyperactivation is a central mechanism in Long COVID pathophysiology, making NAD+ replenishment a mechanistically rational therapeutic target. This research has been widely cited as a basis for clinical investigation of NAD+ interventions in Long COVID. For more detail on the science behind NAD+ and aging, read our post on NAD+ IV therapy — a clinical guide for Baltimore patients.
Insurance, Cost, and the Vita Nova Concierge Service
NAD+ IV therapy is not currently covered by most insurance plans, as it remains an elective and off-label wellness intervention for brain fog and fatigue presentations. Vita Nova’s NAD+ pricing tiers are: $349.99 for 250mg, $549.99 for 500mg, and $899.99 for 750mg to 1,000mg. HSA and FSA accounts are accepted.
Vita Nova offers a dedicated insurance concierge service — our team checks your coverage, handles documentation, and does the administrative work so you can focus on your health rather than insurance paperwork. Check your insurance coverage here and our team will follow up directly.
✅ Insurance Verification Concierge
Wondering if your plan covers NAD+ or other IV therapy? We check your coverage, handle the paperwork, and let you focus on getting well.
❓ Frequently Asked Questions
How many NAD+ infusions do I need for brain fog?
For active brain fog and chronic fatigue, an initial series of 4 to 6 infusions over 2 to 3 weeks is typically recommended to achieve sustained NAD+ elevation and meaningful symptomatic improvement. Following the initial series, monthly or bi-monthly maintenance infusions sustain the benefit. Dr. Joshi determines the protocol based on your clinical presentation.
How quickly will I feel the effects of NAD+ IV therapy?
Many patients report a noticeable improvement in mental clarity and energy within 24 to 48 hours of their first infusion. The full benefit builds progressively across the initial series. Cognitive sharpness, sustained energy, and reduced mental effort are the most commonly reported outcomes after completing the initial protocol.
Is IV NAD+ better than oral NR or NMN supplements for brain fog?
For patients with active brain fog and chronic fatigue symptoms, IV NAD+ achieves plasma concentrations that oral precursors cannot replicate through GI absorption. Oral NR and NMN are appropriate for maintenance between IV sessions and for general wellness support. For therapeutic intervention in symptomatic patients, IV delivery is the clinically meaningful route.
Can NAD+ IV therapy help with post-COVID brain fog?
Emerging research — including work published in Nature Aging — identifies NAD+ depletion as a central mechanism in Long COVID pathophysiology. IV NAD+ therapy targets this specific biochemical deficit directly, making it a mechanistically grounded intervention for post-COVID brain fog and fatigue. Clinical response varies by individual and a physician evaluation is required to determine appropriateness.
Is NAD+ IV therapy safe?
NAD+ has an established safety profile when administered at appropriate doses under physician supervision. Transient side effects during the infusion — such as mild chest pressure, nausea, or a sense of restlessness — are manageable by adjusting the infusion rate and resolve when the infusion ends. All NAD+ sessions at Vita Nova are physician-supervised with continuous monitoring.
How much does NAD+ IV therapy cost in Baltimore?
Vita Nova’s NAD+ pricing is $349.99 for 250mg, $549.99 for 500mg, and $899.99 for 750mg to 1,000mg. Vitality Circle members receive 25% off all NAD+ sessions. HSA and FSA accounts are accepted. Most insurance plans do not currently cover NAD+ for brain fog or fatigue, but our insurance concierge team can verify your specific benefits.
Can I combine NAD+ IV therapy with other treatments at Vita Nova?
Yes. Many patients combine NAD+ with complementary protocols — IV hydration, B12 injections, glutathione, or ketamine therapy for patients with overlapping mental health or pain presentations. Dr. Joshi reviews all current treatments and designs a combined protocol where appropriate. Combining NAD+ with B12 and hydration is a common and clinically supported approach for comprehensive fatigue management.
🔑 Key Takeaways
NAD+ is a fundamental coenzyme required for mitochondrial energy production — when levels decline, the result is brain fog, chronic fatigue, and reduced cognitive performance.
NAD+ levels decline by as much as 50% between the ages of 40 and 60 — a biologically meaningful decline with clinically observable cognitive and energy consequences.
IV NAD+ achieves plasma concentrations that oral NR and NMN supplements cannot replicate — making it the appropriate delivery route for active symptomatic presentations.
Post-COVID brain fog and fatigue are increasingly understood as rooted in NAD+ depletion — making IV NAD+ a mechanistically grounded intervention for Long COVID patients.
Vita Nova’s NAD+ pricing: $349.99 (250mg), $549.99 (500mg), $899.99 (750–1,000mg). Vitality Circle members receive 25% off. NAD+ is not included in the free monthly IV benefit.
All NAD+ sessions at Vita Nova are physician-supervised under Dr. Brijen L. Joshi, MD — individually dosed, continuously monitored, and clinically appropriate for each patient’s presentation.
Vita Nova is located at 513 Bayview Blvd, Baltimore, MD 21224 — serving Baltimore City, Baltimore County, Anne Arundel County, and Howard County with physician-supervised NAD+ IV therapy.
Ready to Clear the Fog and Restore Your Energy?
If brain fog or chronic fatigue is limiting your professional performance, a conversation with Dr. Joshi is the first step. Schedule an in-person consultation at our Canton clinic or start with a telemedicine visit from your office or home.
References
- Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. science.org
- Verdin E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208–1213. science.org
- Xie N, et al. (2022). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 23, 254–270. nature.com
- Massudi H, et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE, 7(7), e42357. plosone.org
- Centers for Disease Control and Prevention. (2024). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. cdc.gov
Tags: NAD+ IV Therapy Baltimore, NAD+ Brain Fog, NAD+ Chronic Fatigue Baltimore, IV NAD+ Baltimore, Post-COVID Brain Fog Baltimore, NAD+ for Energy, Mitochondrial Health Baltimore, Cognitive Performance Baltimore, NAD+ vs Oral Supplements, Vita Nova Baltimore, Dr. Brijen Joshi, Vitality Circle, Baltimore Professionals Wellness, IV Therapy Baltimore
